Moderna says it's on track to report initial COVID-19 vaccine results next month

Moderna is on track to report initial results from its coronavirus vaccine trial next month, company executives said Thursday.

The company is one of the front-runners to produce a vaccine for COVID-19. During an earnings call, Chief Medical Officer Tal Zaks said the trial is operating as planned, and an independent data-monitoring committee is expected to conduct an interim review in November.

The first review from the board will come after the trial reports that 53 cases of COVID-19 have been diagnosed among its sample, and the second interim analysis will come at 106 cases.